CrowdStrike Named a Frost Radar™ Leader in Cloud and Application Runtime Security
CrowdStrike scores highest of all vendors on the Innovation Index as the only CNAPP recognized for unified, real-time protection across cloud, identity and endpoint... Read more.
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds
WHEATON, Ill.–(BUSINESS WIRE)–First Trust Advisors L.P. (“FTA”) announces the declaration of the monthly distributions for certain exchange-traded... Read more.
VSee Health, Inc. Receives Nasdaq Notice on Delayed Form 10-Q Filing
SAN JOSE, Calif.–(BUSINESS WIRE)–VSee Health, Inc. (the “Company”) (Nasdaq: VSEE), announced today that on May 23, 2025, the Company received a notice... Read more.
Duff & Phelps Utility and Infrastructure Fund Inc. Redeems Remaining Floating Rate Mandatory Redeemable Preferred Shares, Series C and Issues Floating Rate Mandatory Redeemable Preferred Shares, Series D
CHICAGO–(BUSINESS WIRE)–Duff & Phelps Utility and Infrastructure Fund Inc. (NYSE: DPG), a closed-end investment management company advised by Duff... Read more.
Mason Capital Management to Support Grifols Recommended Director Slate at Upcoming Ordinary General Meeting
Believes Board Leadership Continuity and Continued Management Focus and Execution Will Drive Long-Term Shareholder Value NEW YORK–(BUSINESS WIRE)–Mason... Read more.
AM Best Affirms Credit Ratings of CESCE México, S.A. de C.V. and CESCE Fianzas México, S.A. de C.V.
MEXICO CITY–(BUSINESS WIRE)–#insurance—AM Best has affirmed the Financial Strength Rating of B++ (Good), the Long-Term Issuer Credit Ratings of... Read more.
APFC Board Examines Asset Allocation, Approves Targeted Portfolio Adjustments
SITKA, Alaska–(BUSINESS WIRE)–The Board of Trustees of the Alaska Permanent Fund Corporation (APFC) held its quarterly meeting and the Ethics, Audit,... Read more.
Johnson Fistel Investigates Quantum Computing: Long Term Investors Encouraged to Reach Out
SAN DIEGO–(BUSINESS WIRE)–Johnson Fistel, PLLP, a shareholder rights law firm, announces it is investigating potential breaches of fiduciary duties by... Read more.
CORRECTING and REPLACING New XOFIGO® (radium-223 dichloride) Data in Metastatic Castration-Resistant Prostate Cancer from Phase III PEACE III Trial Published in Annals of Oncology
XOFIGO® (radium-223 dichloride) in combination with enzalutamide significantly increased radiological progression-free survival (rPFS) for patients with metastatic... Read more.
URGN Investors Have Opportunity to Lead UroGen Pharma Ltd. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against UroGen... Read more.